A DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF INTRAVENOUS METHYLPREDNISOLONE IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：22

作者：

MACKWORTHYOUNG, CG

DAVID, J

MORGAN, SH

HUGHES, GRV

机构：

来源：

ANNALS OF THE RHEUMATIC DISEASES | 1988年 / 47卷 / 06期

关键词：

D O I：

10.1136/ard.47.6.496

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：496 / 502

页数：7

共 50 条

[41] Double blind, randomized, placebo controlled pilot study of leflunomide in systemic lupus erythematosus (SLE)
Tam, LS
Li, EK
Wong, CK
Lam, CWK
Szeto, CC
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 213 - 213
[42] A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
Knobler, RM
French, LE
Kim, Y
Bisaccia, E
Graninger, W
Nahavandi, H
Strobl, FJ
Keystone, E
Mehlmauer, M
Rook, AH
Braverman, I
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (05) : 793 - 799
[43] Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus
Kayode J. Bello
Hong Fang
Parastoo Fazeli
Waleed Bolad
Mary Corretti
Laurence S. Magder
Michelle Petri
[J]. Rheumatology International, 2013, 33 : 2789 - 2796
[44] Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
He, Jing
Zhang, Ruijun
Shao, Miao
Zhao, Xiaozhen
Miao, Miao
Chen, Jiali
Liu, Jiajia
Zhang, Xiaoying
Zhang, Xia
Jin, Yuebo
Wang, Yu
Zhang, Shilei
Zhu, Lei
Jacob, Alexander
Jia, Rulin
You, Xujie
Li, Xue
Li, Chun
Zhou, Yunshan
Yang, Yue
Ye, Hua
Liu, Yanying
Su, Yin
Shen, Nan
Alexander, Jessy
Guo, Jianping
Ambrus, Julian
Lin, Xin
Yu, Di
Sun, Xiaolin
Li, Zhanguo
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 141 - 149
[45] Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus - Results of a multicenter randomized, double-blind, placebo-controlled trial
Petri, MA
Mease, PJ
Merrill, JT
Lahita, RG
Iannini, MJ
Yocum, DE
Ginzler, EM
Katz, RS
Gluck, OS
Genovese, MC
Van Vollenhoven, R
Kalunian, KC
Manzi, S
Greenwald, MW
Buyon, JP
Olsen, NJ
Schiff, MH
Kavanaugh, AF
Caldwell, JR
Ramsey-Goldman, R
St Clair, EW
Goldman, AL
Egan, RM
Polisson, RP
Moder, KG
Rothfield, NF
Spencer, RT
Hobbs, K
Fessler, BJ
Calabrese, LH
Moreland, LW
Cohen, SB
Quarles, BJ
Strand, V
Gurwith, M
Schwartz, KE
[J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : 2858 - 2868
[46] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF METHYLPREDNISOLONE PULSE THERAPY IN ACTIVE RHEUMATOID DISEASE
WILLIAMS, IA
BAYLIS, EM
SHIPLEY, ME
[J]. LANCET, 1982, 2 (8292): : 237 - 240
[47] Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154 - A randomized, double-blind, placebo-controlled trial
Kalunian, KC
Davis, JC
Merrill, JT
Totoritis, MQ
Wofsy, D
[J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3251 - 3258
[48] Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus
Bello, Kayode J.
Fang, Hong
Fazeli, Parastoo
Bolad, Waleed
Corretti, Mary
Magder, Laurence S.
Petri, Michelle
[J]. RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2789 - 2796
[49] Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
Zimmer, Robert
Scherbarth, Hugo R.
Luis Rillo, Oscar
Jesus Gomez-Reino, Juan
Muller, Sylviane
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1830 - 1835
[50] Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Wallace, Daniel J.
Furie, Richard
Tanaka, Yoshiya
Kalunian, Kenneth C.
Mosca, Marta
Petri, Michelle
Dorner, Thomas
Cardiel, Mario H.
Bruce, Ian N.
Gomez, Elisa
DeLozier, Amy M.
Janes, Jonathan
Linnik, Matthew D.
de Bono, Stephanie
Silk, Maria E.
Hoffman, Robert W.
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70

← 1 2 3 4 5 →